UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 32

Sortiert nach

Compound 21 Induces Vasorelaxation via an Endothelium- and Angiotensin II Type 2 Receptor-Independent Mechanism

Hypertension (Dallas, Tex. 1979), 2012-09, Vol.60 (3), p.722-729

2012

Volltextzugriff (PDF)

Hypertension: Renin–Angiotensin–Aldosterone System Alterations

Circulation research, 2015-03, Vol.116 (6), p.960-975

2015

Volltextzugriff (PDF)

Hypertension Induced by the Tyrosine Kinase Inhibitor Sunitinib Is Associated With Increased Circulating Endothelin-1 Levels

Hypertension (Dallas, Tex. 1979), 2010-10, Vol.56 (4), p.675-681

2010

Volltextzugriff (PDF)

Treatment of Hypertension and Renal Injury Induced by the Angiogenesis Inhibitor Sunitinib: Preclinical Study

Hypertension (Dallas, Tex. 1979), 2014-12, Vol.64 (6), p.1282-1289

2014

Volltextzugriff (PDF)

The Vascular Endothelial Growth Factor Receptor Inhibitor Sunitinib Causes a Preeclampsia-Like Syndrome With Activation of the Endothelin System

Hypertension (Dallas, Tex. 1979), 2011-08, Vol.58 (2), p.295-302

2011

Volltextzugriff (PDF)

Angiotensin II Type 2 Receptor– and Acetylcholine-Mediated Relaxation: Essential Contribution of Female Sex Hormones and Chromosomes

Hypertension (Dallas, Tex. 1979), 2015-08, Vol.66 (2), p.396-402

2015

Volltextzugriff (PDF)

Selective Angiotensin-Converting Enzyme C-Domain Inhibition Is Sufficient to Prevent Angiotensin I–Induced Vasoconstriction

Hypertension (Dallas, Tex. 1979), 2005-01, Vol.45 (1), p.120-125

2005

Volltextzugriff (PDF)

Effects of Angiotensin Metabolites in the Coronary Vascular Bed of the Spontaneously Hypertensive Rat: Loss of Angiotensin II Type 2 Receptor-Mediated Vasodilation

Hypertension (Dallas, Tex. 1979), 2010-02, Vol.55 (2, Part 2 Suppl), p.516-522

2010

Volltextzugriff (PDF)

The (pro)renin receptor blocker handle region peptide upregulates endothelium-derived contractile factors in aliskiren-treated diabetic transgenic (mREN2)27 rats

Journal of hypertension, 2013-02, Vol.31 (2), p.292-302

2013

Volltextzugriff (PDF)

Handle Region Peptide Counteracts the Beneficial Effects of the Renin Inhibitor Aliskiren in Spontaneously Hypertensive Rats

Hypertension (Dallas, Tex. 1979), 2011-04, Vol.57 (4), p.852-858

2011

Volltextzugriff (PDF)

The role of the renin-angiotensin system in thoracic aortic aneurysms: clinical implications

Pharmacology & therapeutics (Oxford), 2011-07, Vol.131 (1), p.50-60

2011

Volltextzugriff (PDF)

Effects of angiotensin II and its metabolites in the rat coronary vascular bed : Is angiotensin III the preferred ligand of the angiotensin AT2 receptor?

European journal of pharmacology, 2008-07, Vol.588 (2-3), p.286-293

2008

Volltextzugriff (PDF)

Cardiovascular phenotype of mice lacking all three subtypes of angiotensin II receptors

The FASEB journal, 2008-08, Vol.22 (8), p.3068-3077

2008

Volltextzugriff (PDF)

On the Origin of Urinary Angiotensin II

Hypertension (Dallas, Tex. 1979), 2010-10, Vol.56 (4), p.e45-e45

2010

Volltextzugriff (PDF)

Hypertension during vascular endothelial growth factor inhibition: focus on nitric oxide, endothelin-1, and oxidative stress

Antioxidants & redox signaling, 2014-01, Vol.20 (1), p.135

2014

Volltextzugriff (PDF)

Sunitinib-Induced Hypothyroidism Is due to Induction of Type 3 Deiodinase Activity and Thyroidal Capillary Regression

The journal of clinical endocrinology and metabolism, 2011-10, Vol.96 (10), p.3087-3094

2011

Volltextzugriff (PDF)

Letter by Krop et al regarding article, "Role of p90 ribosomal S6 kinase-mediated prorenin-converting enzyme in ischemic and diabetic myocardium"

Circulation (New York, N.Y.), 2006-10, Vol.114 (17), p.e556; author reply e557-e556; author reply e557

2006

Volltextzugriff (PDF)

Mechanism of hypertension and proteinuria during angiogenesis inhibition: evolving role of endothelin-1

Journal of hypertension, 2013-03, Vol.31 (3), p.444-454

2013

Volltextzugriff (PDF)

Cardiovascular and renal toxicity during angiogenesis inhibition: clinical and mechanistic aspects

Journal of hypertension, 2009-12, Vol.27 (12), p.2297-2309

2009

Volltextzugriff (PDF)

Angiotensin II type 2 receptor agonists: where should they be applied?

Expert opinion on investigational drugs, 2012-04, Vol.21 (4), p.501-513

2012

Volltextzugriff (PDF)

Beneficial cardiac effects of the renin inhibitor aliskiren in spontaneously hypertensive rats

Journal of hypertension, 2010-10, Vol.28 (10), p.2145-2155

2010

Volltextzugriff (PDF)

The genetic architecture of phenotypic diversity in the Betta fish ( Betta splendens )

Science advances, 2022-09, Vol.8 (38), p.eabm4955-eabm4955

2022

Volltextzugriff (PDF)

Deterioration of kidney function by the (pro)renin receptor blocker handle region peptide in aliskiren-treated diabetic transgenic (mRen2)27 rats

American journal of physiology. Renal physiology, 2014-05, Vol.306 (10), p.F1179-F1189

2014

Volltextzugriff (PDF)

Impaired vascular contractility and aortic wall degeneration in fibulin-4 deficient mice: effect of angiotensin II type 1 (AT1) receptor blockade

PloS one, 2011-08, Vol.6 (8), p.e23411-e23411

2011

Volltextzugriff (PDF)

Prorenin and the (pro)renin receptor—an update

Nephrology, dialysis, transplantation, 2007-05, Vol.22 (5), p.1288-1292

2007

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(32)

Sprache

Englisch
(32)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

Science & Technology
(26)
Animals
(25)
Life Sciences & Biomedicine
(24)
Cardiovascular System & Cardiology
(16)
Male
(16)
Peripheral Vascular Disease
(16)
Biological And Medical Sciences
(15)
Medical Sciences
(15)
Humans
(14)
Rats
(14)
Cardiology. Vascular System
(13)
Angiotensin
(11)
Arterial Hypertension. Arterial Hypotension
(11)
Blood And Lymphatic Vessels
(11)
Female
(9)
Blood Pressure - Drug Effects
(7)
Angiotensin Ii - Metabolism
(6)
Angiotensin Ii - Pharmacology
(6)
Hypertension
(6)
Hypertension - Physiopathology
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Compound 21 Induces Vasorelaxation via an Endothelium- and Angiotensin II Type 2 Receptor-Independent Mechanism

Hypertension: Renin–Angiotensin–Aldosterone System Alterations

Hypertension Induced by the Tyrosine Kinase Inhibitor Sunitinib Is Associated With Increased Circulating Endothelin-1 Levels

Treatment of Hypertension and Renal Injury Induced by the Angiogenesis Inhibitor Sunitinib: Preclinical Study

The Vascular Endothelial Growth Factor Receptor Inhibitor Sunitinib Causes a Preeclampsia-Like Syndrome With Activation of the Endothelin System

Angiotensin II Type 2 Receptor– and Acetylcholine-Mediated Relaxation: Essential Contribution of Female Sex Hormones and Chromosomes

Selective Angiotensin-Converting Enzyme C-Domain Inhibition Is Sufficient to Prevent Angiotensin I–Induced Vasoconstriction

Effects of Angiotensin Metabolites in the Coronary Vascular Bed of the Spontaneously Hypertensive Rat: Loss of Angiotensin II Type 2 Receptor-Mediated Vasodilation

The (pro)renin receptor blocker handle region peptide upregulates endothelium-derived contractile factors in aliskiren-treated diabetic transgenic (mREN2)27 rats

Handle Region Peptide Counteracts the Beneficial Effects of the Renin Inhibitor Aliskiren in Spontaneously Hypertensive Rats

The role of the renin-angiotensin system in thoracic aortic aneurysms: clinical implications

Effects of angiotensin II and its metabolites in the rat coronary vascular bed : Is angiotensin III the preferred ligand of the angiotensin AT2 receptor?

Cardiovascular phenotype of mice lacking all three subtypes of angiotensin II receptors

On the Origin of Urinary Angiotensin II

Hypertension during vascular endothelial growth factor inhibition: focus on nitric oxide, endothelin-1, and oxidative stress

Sunitinib-Induced Hypothyroidism Is due to Induction of Type 3 Deiodinase Activity and Thyroidal Capillary Regression

Letter by Krop et al regarding article, "Role of p90 ribosomal S6 kinase-mediated prorenin-converting enzyme in ischemic and diabetic myocardium"

Mechanism of hypertension and proteinuria during angiogenesis inhibition: evolving role of endothelin-1

Cardiovascular and renal toxicity during angiogenesis inhibition: clinical and mechanistic aspects

Angiotensin II type 2 receptor agonists: where should they be applied?

Beneficial cardiac effects of the renin inhibitor aliskiren in spontaneously hypertensive rats

The genetic architecture of phenotypic diversity in the Betta fish ( Betta splendens )

Deterioration of kidney function by the (pro)renin receptor blocker handle region peptide in aliskiren-treated diabetic transgenic (mRen2)27 rats

Impaired vascular contractility and aortic wall degeneration in fibulin-4 deficient mice: effect of angiotensin II type 1 (AT1) receptor blockade

Prorenin and the (pro)renin receptor—an update

Suchergebnisse filtern